Des traitements expérimentaux, comme la thérapie génique, sont en cours d'évaluation.
Thérapie géniqueTraitements expérimentaux
#4
Les traitements sont-ils personnalisés ?
Oui, les traitements peuvent être adaptés en fonction des besoins individuels du patient.
Médecine personnaliséeAdaptation du traitement
#5
Quel rôle joue la rééducation dans le traitement ?
La rééducation est essentielle pour améliorer la fonction et la qualité de vie des patients.
RééducationFonction
Complications
5
#1
Quelles complications peuvent survenir avec des troubles gliaux ?
Les complications incluent des troubles cognitifs, des crises épileptiques et des troubles de l'humeur.
Troubles cognitifsCrises épileptiques
#2
Les complications sont-elles réversibles ?
Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non.
RéversibilitéTraitement approprié
#3
Comment les complications affectent-elles le quotidien ?
Elles peuvent entraîner des limitations dans les activités quotidiennes et la vie sociale.
Activités quotidiennesVie sociale
#4
Y a-t-il des risques de complications à long terme ?
Oui, des complications à long terme peuvent survenir, affectant la santé mentale et physique.
Risques à long termeSanté mentale
#5
Les complications nécessitent-elles une surveillance continue ?
Oui, une surveillance régulière est essentielle pour gérer les complications et ajuster le traitement.
SurveillanceGestion des complications
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque pour les troubles gliaux ?
Les facteurs de risque incluent des antécédents familiaux, des infections et des traumatismes crâniens.
Antécédents familiauxTraumatismes crâniens
#2
L'âge est-il un facteur de risque ?
Oui, certains troubles gliaux sont plus fréquents chez les personnes âgées ou les jeunes enfants.
ÂgeTroubles gliaux
#3
Le mode de vie influence-t-il les risques ?
Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter les risques.
Mode de vieAlimentation
#4
Les maladies auto-immunes sont-elles un facteur de risque ?
Oui, certaines maladies auto-immunes peuvent affecter la fonction gliale et augmenter les risques.
Maladies auto-immunesFonction gliale
#5
Y a-t-il des facteurs génétiques impliqués ?
Oui, des mutations génétiques peuvent prédisposer certains individus à des troubles gliaux.
Facteurs génétiquesMutations
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteur de maturation gliale : Questions médicales les plus fréquentes",
"headline": "Facteur de maturation gliale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteur de maturation gliale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-02",
"dateModified": "2025-04-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteur de maturation gliale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs de croissance nerveuse",
"url": "https://questionsmedicales.fr/mesh/D009414",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de croissance nerveuse",
"code": {
"@type": "MedicalCode",
"code": "D009414",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.850"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Facteur de maturation gliale",
"alternateName": "Glia Maturation Factor",
"code": {
"@type": "MedicalCode",
"code": "D020904",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duraisamy Kempuraj",
"url": "https://questionsmedicales.fr/author/Duraisamy%20Kempuraj",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
},
{
"@type": "Person",
"name": "Ramasamy Thangavel",
"url": "https://questionsmedicales.fr/author/Ramasamy%20Thangavel",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
},
{
"@type": "Person",
"name": "Mohammad Ejaz Ahmed",
"url": "https://questionsmedicales.fr/author/Mohammad%20Ejaz%20Ahmed",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
},
{
"@type": "Person",
"name": "Govindhasamy Pushpavathi Selvakumar",
"url": "https://questionsmedicales.fr/author/Govindhasamy%20Pushpavathi%20Selvakumar",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
},
{
"@type": "Person",
"name": "Sudhanshu P Raikwar",
"url": "https://questionsmedicales.fr/author/Sudhanshu%20P%20Raikwar",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, and the Center for Translational Neuroscience, School of Medicine, University of Missouri, Columbia, MO, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effect of Mean Platelet Volume to Platelet Count Ratio on Mortality in Peritoneal Dialysis.",
"datePublished": "2022-11-10",
"url": "https://questionsmedicales.fr/article/36405991",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/6922809"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neonatal Thrombocytopenia: Factors Associated With the Platelet Count Increment Following Platelet Transfusion.",
"datePublished": "2023-08-11",
"url": "https://questionsmedicales.fr/article/37572863",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jpeds.2023.113666"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of platelet count and platelet transfusion on fever duration in patients with febrile neutropenia.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35855637",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/08880018.2022.2066236"
}
},
{
"@type": "ScholarlyArticle",
"name": "Platelet count, temperature and pH value differentially affect hemostatic and immunomodulatory functions of platelets.",
"datePublished": "2023-01-27",
"url": "https://questionsmedicales.fr/article/36738664",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.thromres.2023.01.026"
}
},
{
"@type": "ScholarlyArticle",
"name": "Platelet count in preeclampsia: a systematic review and meta-analysis.",
"datePublished": "2023-04-24",
"url": "https://questionsmedicales.fr/article/37098392",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajogmf.2023.100979"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs de croissance nerveuse",
"item": "https://questionsmedicales.fr/mesh/D009414"
},
{
"@type": "ListItem",
"position": 5,
"name": "Facteur de maturation gliale",
"item": "https://questionsmedicales.fr/mesh/D020904"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteur de maturation gliale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteur de maturation gliale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteur de maturation gliale",
"description": "Comment diagnostiquer une anomalie des facteurs de maturation gliale ?\nQuels tests sont utilisés pour évaluer les facteurs gliaux ?\nLes facteurs de maturation gliale sont-ils mesurables ?\nQuels signes cliniques indiquent un problème glial ?\nLes tests génétiques sont-ils utiles pour ces facteurs ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Platelet+Count#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteur de maturation gliale",
"description": "Quels symptômes sont liés à une dysfonction gliale ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes physiques associés ?\nLes symptômes sont-ils réversibles ?\nComment les symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Platelet+Count#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteur de maturation gliale",
"description": "Peut-on prévenir les troubles liés aux facteurs gliaux ?\nY a-t-il des facteurs environnementaux à éviter ?\nL'éducation joue-t-elle un rôle dans la prévention ?\nLes vaccinations peuvent-elles prévenir des troubles gliaux ?\nLe soutien psychologique est-il préventif ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Platelet+Count#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteur de maturation gliale",
"description": "Quels traitements sont disponibles pour les troubles gliaux ?\nLes thérapies comportementales sont-elles efficaces ?\nY a-t-il des traitements expérimentaux ?\nLes traitements sont-ils personnalisés ?\nQuel rôle joue la rééducation dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Platelet+Count#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteur de maturation gliale",
"description": "Quelles complications peuvent survenir avec des troubles gliaux ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles le quotidien ?\nY a-t-il des risques de complications à long terme ?\nLes complications nécessitent-elles une surveillance continue ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Platelet+Count#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteur de maturation gliale",
"description": "Quels sont les principaux facteurs de risque pour les troubles gliaux ?\nL'âge est-il un facteur de risque ?\nLe mode de vie influence-t-il les risques ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nY a-t-il des facteurs génétiques impliqués ?",
"url": "https://questionsmedicales.fr/mesh/D020904?mesh_terms=Platelet+Count#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des facteurs de maturation gliale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des analyses histologiques des tissus nerveux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les facteurs gliaux ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie cérébrale et des biopsies peuvent être utilisés pour évaluer les facteurs gliaux."
}
},
{
"@type": "Question",
"name": "Les facteurs de maturation gliale sont-ils mesurables ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dosages spécifiques dans le liquide céphalorachidien peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un problème glial ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques, des déficits cognitifs ou des symptômes psychiatriques peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour ces facteurs ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations associées aux anomalies des facteurs gliaux."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysfonction gliale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles de la mémoire, des convulsions et des changements de comportement."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et du stade de développement neurologique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes physiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes physiques comme des douleurs ou des faiblesses musculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la cause sous-jacente; certains symptômes peuvent être réversibles avec un traitement."
}
},
{
"@type": "Question",
"name": "Comment les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent gravement affecter la qualité de vie, entraînant des limitations fonctionnelles et sociales."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux facteurs gliaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures préventives, comme une bonne nutrition et l'exercice, peuvent aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines et à des infections peut augmenter le risque de troubles gliaux."
}
},
{
"@type": "Question",
"name": "L'éducation joue-t-elle un rôle dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les signes précoces peut aider à une intervention rapide et efficace."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir des troubles gliaux ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui affectent le système nerveux."
}
},
{
"@type": "Question",
"name": "Le soutien psychologique est-il préventif ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien psychologique peut réduire le stress et améliorer la résilience face aux troubles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles gliaux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, la thérapie physique et des interventions chirurgicales si nécessaire."
}
},
{
"@type": "Question",
"name": "Les thérapies comportementales sont-elles efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent aider à gérer les symptômes psychiatriques associés aux troubles gliaux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme la thérapie génique, sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des besoins individuels du patient."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la rééducation dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rééducation est essentielle pour améliorer la fonction et la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles gliaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles cognitifs, des crises épileptiques et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles le quotidien ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des limitations dans les activités quotidiennes et la vie sociale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications à long terme peuvent survenir, affectant la santé mentale et physique."
}
},
{
"@type": "Question",
"name": "Les complications nécessitent-elles une surveillance continue ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière est essentielle pour gérer les complications et ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les troubles gliaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent des antécédents familiaux, des infections et des traumatismes crâniens."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles gliaux sont plus fréquents chez les personnes âgées ou les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter la fonction gliale et augmenter les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs génétiques impliqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations génétiques peuvent prédisposer certains individus à des troubles gliaux."
}
}
]
}
]
}
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Pharmacology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Department of Ophthalmology of Shanghai Tenth's People Hospital and Laboratory of Clinical Visual Science of Tongji Eye Institute, Tongji University, Shanghai, China.
Department of Biochemistry and Molecular Biology, School of Medicine, Tongji University, Shanghai, China.
Publications dans "Facteur de maturation gliale" :
Mean platelet volume to platelet count ratio (MPV/PC) has been found to be an independent risk factor for mortality in various diseases, including cardiovascular disease, cancer, and hemodialysis. We ...
We conducted a retrospective cohort study at a single center and enrolled 1473 PD patients who were catheterized at our PD center from January 1, 2006, to December 31, 2013. All patients were divided ...
Our results indicated that low MPV/PC level was an independent risk factor for all-cause and CV mortality in PD patients aged less than 60 years....
To understand better those factors relevant to the increment of rise in platelet count following a platelet transfusion among thrombocytopenic neonates....
We reviewed all platelet transfusions over 6 years in our multi-neonatal intensive care unit system. For every platelet transfusion in 8 neonatal centers we recorded: (1) platelet count before and aft...
We evaluated 1797 platelet transfusions administered to 605 neonates (median one/recipient, mean 3, and range 1-52). The increment was not associated with gestational age at birth, postnatal age at tr...
The magnitude of post-transfusion rise was unaffected by most variables we studied. However, the increment was lower in neonates with consumptive thrombocytopenia, after pathogen reduction, with longe...
Platelets play a role in hemostasis, thrombosis, and vascular integrity. They also play a major role in the development of inflammation and the activation of immune responses. They have phagocytic act...
Platelets are primarily recognized for their role in hemostasis, but also regulate immune responses by interacting with leukocytes. Their highly sensitive nature enables platelets to rapidly respond t...
Many studies have reported the association between platelets and preeclampsia. However, sample sizes were small, and their findings were inconsistent. We conducted a systematic review and meta-analysi...
A systematic literature search was performed using Medline, Embase, ScienceDirect, Web of Science, Cochrane Library, NICHD-DASH, LILACS, and Scopus from inception to April 22, 2022....
Observational studies comparing platelet count between women with preeclampsia and normotensive pregnant women were included....
The mean differences with 95% confidence interval in platelet count were calculated. Heterogeneity was assessed using I...
A total of 56 studies comprising 4892 preeclamptic and 9947 normotensive pregnant women were included. Meta-analysis showed that platelet count was significantly lower in women with preeclampsia than ...
This meta-analysis confirmed that platelet count was significantly lower in preeclamptic women, irrespective of severity and presence or absence of associated complications, even before the onset of p...
Megakaryocytes (MKs), a kind of functional hematopoietic stem cell, form platelets to maintain platelet balance through cell differentiation and maturation. In recent years, the incidence of blood dis...
Platelet transfusion is commonly performed in infants to correct severe thrombocytopenia or prevent bleeding. Exploring the associations of platelet transfusion, platelet count (PC), and mean platelet...
To evaluate the associations of platelet transfusion, PC, and MPV with IVH and in-hospital mortality and to explore whether platelet transfusion-associated IVH and mortality risks vary with PC and MPV...
This retrospective cohort study included preterm infants who were transferred to the neonatal intensive care unit on their day of birth and received ventilation during their hospital stay. The study w...
Platelet transfusion, PC, and MPV....
Any grade IVH, severe IVH (grade 3 or 4), and in-hospital mortality....
Among the 1221 preterm infants (731 [59.9%] male; median [IQR] gestational age, 31.0 [29.0-33.0] weeks), 94 (7.7%) received 166 platelet transfusions. After adjustment for potential confounders, plate...
In preterm infants, platelet transfusion, PC, and MPV were associated with mortality, and PC was also associated with any grade IVH and severe IVH. The findings suggest that a lower platelet transfusi...
The familial chylomicronemia syndrome (FCS) is an ultra rare disease caused by lipoprotein lipase (LPL) deficiency associated with potentially lethal acute pancreatitis risk. Thrombocytopenia (platele...
To evaluate post-prandial fluctuations in the platelet count (PLC) and functional defects of hemostasis in FCS....
PLC, functional defects in hemostasis and hematologic variables were measured up-to 5 h after a meal in 6 homozygotes for FCS causing gene variants (HoLPL), 6 heterozygotes for LPL loss-of-function va...
Hourly post-prandial PLC was significantly lower in HoLPL than in controls (P < 0.009). Compared to the other groups, the PLC tended to decrease rapidly (in the first hour) post-meal in HoLPL (P = 0.0...
The PLC decreases post-prandially in FCS (HoLPL), is not associated with changes in functional defects of hemostasis and correlates with the NLR, a marker of acute pancreatitis severity....
This study aimed to evaluate the role of platelet count (PLT) in the prognosis of patients with acute respiratory distress syndrome (ARDS)....
The data were extracted from the Medical Information Mart for Intensive Care database (version 2.2). Patients diagnosed with ARDS according to criteria from Berlin Definition and had the platelet coun...
Overall, the final analysis included 3,207 eligible participants with ARDS. According to the Kaplan-Meier curves for 28-day mortality of PLT, PLT ≤ 100 × 10...
PLT appeared to be an independent predictor of mortality in critically ill patients with ARDS....
Linezolid (LZD) is one of the antibiotics used to treat methicillin-resistant Staphylococcus aureus. In Japan, the dose of LZD is not generally adjusted by renal function or therapeutic drug monitorin...
Fifty-five critically ill patients with existing thrombocytopenia (platelet count < 100 ×103 /μL) who received LZD for five days or more during the period from January 2011 to October 2018 were includ...
Mean (± standard error) platelet count prior to initiation of LZD was 47 ± 4 ×103 /uL, which increased significantly to 86 ± 13 ×103 /uL on day 15 (p<0.01). Median [interquartile range] duration of LZ...
Thrombocytopenia in critically ill patients in the ICU did not worsen after initiation of LZD therapy, and may be considered for the treatment of MRSA in this setting....
